BioSpace News Archive

Pharm Country

Delcath Systems to Participate at the H.C. Wainwright 25th Annual Investor Conference on September 12 and 13, 2023

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will participate at the H.C Wainwright 25th Annual Global Investor Conference.

September 5, 2023
·
1 min read
Pharm Country

Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement

Ascendis Pharma A/S and Royalty Pharma plc announced that Ascendis has entered into a $150 million capped synthetic royalty funding agreement with Royalty Pharma based on U.S. net SKYTROFA revenue.

September 5, 2023
·
10 min read
Business

Ascendis Pharma Reports Second Quarter 2023 Financial Results

Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the second quarter ended June 30, 2023 and provided business updates.

September 5, 2023
·
14 min read
Genetown

Karyopharm to Participate at Upcoming September 2023 Investor Conferences

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Company’s senior management team will participate in the following investor conferences in September.

September 5, 2023
·
1 min read
Genetown

bluebird bio Announces September 2023 Investor Events

bluebird bio, Inc. announced that members of the management team will participate in fireside chats at the following upcoming investor conferences.

September 5, 2023
·
1 min read
Business

uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe EpilepsyClinical trial initiation expected in the fourth quarter of 2023

uniQure N.V. announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for AMT-260, the Company’s gene therapy candidate for refractory mesial temporal lobe epilepsy.

September 5, 2023
·
4 min read
Pharm Country

GSK and Earvin “Magic” Johnson to Host Community Awareness Events about Older Adult Risk for RSV at YMCA Locations

GSK plc and YMCA of the USA will host GSK’s Sideline RSV “Community Conversations” event series as part of their campaign efforts to raise awareness about RSV infection in older adults.

September 5, 2023
·
6 min read